|
 |
Harry Glorikian
Founder and
Managing Partner
Scientia Advisors |
|
Harry Glorikian
heads Scientia Advisors with 20
years of experience in the
health care and life science
industries. He is known
worldwide as a leader in helping
companies streamline their
operations and accelerate their
growth.
Having held senior management
positions at Applied Bio
Systems, Signet Laboratories, in
Massachusetts, and at X-Cell
Laboratories, Inc., in
California, Harry has deep
commercial background in
diagnostics, molecular biology,
proteomics, cellular biology and
biodefense. His unique
understanding of technologies,
operations and strategy from
both customer and industry
player perspectives has shaped
Scientia's sophisticated
framework and proprietary
analytic tools.
A sought-after speaker, Harry
has addressed the National
Institutes of Health, Molecular
Medicine Tri-Conference and
other audiences, worldwide. He
has authored numerous articles
for industry publications,
appeared on CBS Evening News and
been quoted by Dow Jones, the
Boston Globe, BioWorld Today,
Los Angeles Times, London
Independent, Medical Device
Daily, Science Magazine and many
other media outlets.
Harry holds an MBA from Boston
University and a BA in Biology
from San Francisco State
University. He serves on many
advisory boards and is an avid
inventor who has several patents
and patents pending in the US
and abroad.
|
|
